Serum soluble FMS-like tyrosine kinase 1 and placental growth factor concentration as predictors of preeclampsia in high risk pregnant women

Malaysian Journal of Pathology

Volumn 36, Issue 1, 2014, Pages 19-26

  Hanita, O ^a   Alia, N N ^a   Zaleha, A M ^a   Nor Azlin, M I ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Placental growth factor; Preeclampsia; Soluble Fms like tyrosine kinase 1

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HIGH RISK PREGNANCY; HUMAN; IMMUNOASSAY; PREDICTIVE VALUE; PREDICTOR VARIABLE; PREECLAMPSIA; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY PROTEINS; RISK FACTORS; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; YOUNG ADULT;

EID: 84899410952     PISSN: 01268635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Villar J, Say L, Gulmezoglu AM, et al. Preeclampsia: A health problem for 2000 years. In: Critchly H, MacLean A, Poston L, Walker J, editors. Pre-eclampsia. London, England: RCOG Press; 2003. p. 189-207.
2. Malaysian National Committee of Parliamentarians on Population Development and Reproductive Health. Maternal morbidity in Malaysia; 2006.
3. Widmer M, Villar J, Benigni A, Conde-Agudelo A, Karumanchi SA, Lindheimer M. Mapping the theories of preeclampsia and the role of angiogenic factors: A systematic review. Obstet Gynaecol. 2007; 109(1): 168-80.
4. Mignini LE, Latthe PM, Villar J, Kilby MD, Carroli G, Khan KS. Mapping the theories of preeclampsia: the role of homocysteine. Obstet Gynaecol. 2005; 105(2): 411-25.
5. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension and proteinuria in preeclampsia. J Clin Invest. 2003; 111(5): 649-58.
6. Maynard, SE, Venkatesha S, Thadhani, R, Karumanchi SA. Soluble fms-like tyrosine kinase 1 and endothelial dysfunction in the pathogenesis of preeclampsia. Pediatr Res. 2005; 57(5 Pt 2): 1R-7R.
7. Australasian Society for the Study of Hypertension in Pregnancy (ASSHP). Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183(1): S1-22.
8. Makris A, Thornton C, Thompson J, et al. Uteroplacental ischemia results in proteinuric hypertension and elevated sFlt-1. Kidney Int. 2007; 71(10): 977-84.
9. Powers, RW, Jeyabalan, A, Clifton, R.G, et al. Soluble fms-like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies. PLoS One. 2010; 5(10): e13263.
10. Verlohren S, Galindo A, Schlembach, D, et al. An automated method for the determination of the sFlt-1/PlGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol. 2010; 202(2): 161.e1-161.e11.
11. Sibai BM, Koch MA, Freire S, et al. Serum inhibin A and angiogenic factor levels in pregnancies with previous preeclampsia and/or chronic hypertension: are they useful markers for prediction of subsequent preeclampsia. Am J Obstet Gynecol. 2008; 199(3): 268.e1-9.
12. Levine RJ, Lam C. Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006; 355(10): 992-1005.
13. Kim SY, Ryu HM, Yang JH, et al. Increased sFlt-1 to PlGF ratio in women who subsequently develop preeclampsia. J Korean Med Sci. 2007; 22(5): 873-7.
14. Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol. 2007; 197(3): 244. e1-8.
15. Ohkuchi A, Hirashima C, Suzuki H, et al. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010; 33(5): 422-7.